234 related articles for article (PubMed ID: 35941657)
1. Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.
Dreijerink KMA; Ozyerli-Goknar E; Koidl S; van der Lelij EJ; van den Heuvel P; Kooijman JJ; Biniossek ML; Rodenburg KW; Nizamuddin S; Timmers HTM
Epigenetics Chromatin; 2022 Aug; 15(1):29. PubMed ID: 35941657
[TBL] [Abstract][Full Text] [Related]
2. The same pocket in menin binds both MLL and JUND but has opposite effects on transcription.
Huang J; Gurung B; Wan B; Matkar S; Veniaminova NA; Wan K; Merchant JL; Hua X; Lei M
Nature; 2012 Feb; 482(7386):542-6. PubMed ID: 22327296
[TBL] [Abstract][Full Text] [Related]
3. Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.
Dreijerink KMA; Timmers HTM; Brown M
Endocr Relat Cancer; 2017 Oct; 24(10):T135-T145. PubMed ID: 28811299
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors.
Agarwal SK; Jothi R
PLoS One; 2012; 7(5):e37952. PubMed ID: 22666422
[TBL] [Abstract][Full Text] [Related]
5. Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms.
Shimazu S; Nagamura Y; Yaguchi H; Ohkura N; Tsukada T
Cancer Sci; 2011 Nov; 102(11):2097-102. PubMed ID: 21819486
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of JunD missense mutants that lack menin binding.
Knapp JI; Heppner C; Hickman AB; Burns AL; Chandrasekharappa SC; Collins FS; Marx SJ; Spiegel AM; Agarwal SK
Oncogene; 2000 Sep; 19(41):4706-12. PubMed ID: 11032020
[TBL] [Abstract][Full Text] [Related]
8. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.
Lin W; Watanabe H; Peng S; Francis JM; Kaplan N; Pedamallu CS; Ramachandran A; Agoston A; Bass AJ; Meyerson M
Mol Cancer Res; 2015 Apr; 13(4):689-98. PubMed ID: 25537453
[TBL] [Abstract][Full Text] [Related]
9. Menin links estrogen receptor activation to histone H3K4 trimethylation.
Dreijerink KM; Mulder KW; Winkler GS; Höppener JW; Lips CJ; Timmers HT
Cancer Res; 2006 May; 66(9):4929-35. PubMed ID: 16651450
[TBL] [Abstract][Full Text] [Related]
10. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription.
Agarwal SK; Guru SC; Heppner C; Erdos MR; Collins RM; Park SY; Saggar S; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ; Burns AL
Cell; 1999 Jan; 96(1):143-52. PubMed ID: 9989505
[TBL] [Abstract][Full Text] [Related]
11. Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia.
Chen Y; Jones KL; Anastassiadis K; Kranz A; Stewart AF; Grembecka J; Meyerson M; Ernst P
Exp Hematol; 2019 Jan; 69():37-42. PubMed ID: 30315824
[TBL] [Abstract][Full Text] [Related]
12. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
13. Menin and JunD regulate gastrin gene expression through proximal DNA elements.
Mensah-Osman EJ; Veniaminova NA; Merchant JL
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G783-90. PubMed ID: 21852362
[TBL] [Abstract][Full Text] [Related]
14. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Murat A; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Parfait B; Chabre O; Castermans E; Beckers A; Ruszniewski P; Le Bras M; Delemer B; Bouchard P; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Penfornis A; Bihan H; Archambeaud F; Kerlan V; Duron F; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
Hum Mol Genet; 2013 May; 22(10):1940-8. PubMed ID: 23376981
[TBL] [Abstract][Full Text] [Related]
15. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).
Canaff L; Vanbellinghen JF; Kaji H; Goltzman D; Hendy GN
J Biol Chem; 2012 Mar; 287(11):8584-97. PubMed ID: 22275377
[TBL] [Abstract][Full Text] [Related]
16. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.
Gurung B; Feng Z; Iwamoto DV; Thiel A; Jin G; Fan CM; Ng JM; Curran T; Hua X
Cancer Res; 2013 Apr; 73(8):2650-8. PubMed ID: 23580576
[TBL] [Abstract][Full Text] [Related]
17. The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.
Dreijerink KM; Varier RA; van Beekum O; Jeninga EH; Höppener JW; Lips CJ; Kummer JA; Kalkhoven E; Timmers HT
Mol Cell Biol; 2009 Sep; 29(18):5060-9. PubMed ID: 19596783
[TBL] [Abstract][Full Text] [Related]
18. Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism.
Gobl AE; Berg M; Lopez-Egido JR; Oberg K; Skogseid B; Westin G
Biochim Biophys Acta; 1999 Oct; 1447(1):51-6. PubMed ID: 10500243
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type 1: a chromatin writer's block.
Dreijerink KM; Lips CJ; Timmers HT
J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
[TBL] [Abstract][Full Text] [Related]
20. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
